1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
LRA/RRF Empowering Lupus Research Scientist Development Award is a joint grant program from the Lupus Research Alliance and Rheumatology Research Foundation committing $1. 9 million in total to support early-career scientists and junior investigators advancing lupus and rheumatology research.
The Scientist Development Award provides up to $225,000 over three years, while the companion Investigator Award provides up to $500,000 over four years. Five early-career scientists were selected for 2026 awards, pursuing research into lupus connections with menopause, cardiovascular disease, immunometabolism, and aging. The program supports exploration of understudied pathways, innovative concepts, and translational work.
Submissions undergo rigorous peer review by the Foundation's Peer Review Study Sections. Eligible applicants are early-career scientists and junior investigators in rheumatology and lupus research.
Get alerted about grants like this
Save a search for “Lupus Research Alliance (LRA) and Rheumatology Research Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The Lupus Research Alliance and Rheumatology Research Foundation Commit $1. 9M to Empower Early-Career Scientists - Lupus Research Alliance The Lupus Research Alliance and Rheumatology Research Foundation Commit $1. 9M to Empower Early-Career Scientists Leading rheumatology research organizations unite to support the research workforce and fuel lupus breakthroughs.
ATLANTA , Georgia , April 2, 2026 — Today, the Lupus Research Alliance (LRA) , in partnership with the Rheumatology Research Foundation (Foundation) , committed $1. 9 million in grants through the Empowering Lupus Research Partnership to support early-career scientists and junior investigators advancing rheumatology and lupus research.
Lupus, a chronic autoimmune condition that causes widespread inflammation and tissue damage, impacts millions of people globally. The initiative backs exploration of understudied pathways, innovative concepts, and translational work aimed at deepening our understanding of the disease to ultimately improve prevention and treatment.
Five early-career scientists and junior investigators were selected for the 2026 award and will focus on lupus and its connections to menopause, cardiovascular disease, immunometabolism, and aging, among other topics. “The research community is navigating a volatile federal funding climate that could have long-term effects on scientific progress,” said Eryn Marchiolo, executive director of the Rheumatology Research Foundation .
“By pooling our resources, we can respond quickly to strengthen the research pipeline. Our hope is that this funding sparks breakthroughs that bring answers and comfort to people affected by lupus. ” The Empowering Lupus Research Partnership grants are administered through two Foundation-managed awards: the Scientist Development Award (up to $225,000 over three years) and the Investigator Award (up to $500,000 over four years).
Submissions underwent rigorous peer review led by the Foundation’s Peer Review Study Sections, which evaluated applications to identify the most promising projects advancing lupus research. The chosen recipients each represent varied clinical and research settings. “Behind every discovery are dedicated investigators who need dependable support,” said Teodora Staeva, PhD, Chief Scientific Officer of the Lupus Research Alliance.
“This collaborative investment ensures early-career researchers can continue driving forward the advancements that people living with lupus urgently need. ” Lupus disproportionately affects women —who make up 90% of diagnoses—and occurs at higher rates among African American, Hispanic, Asian, and Native American/Alaskan Native populations.
The disease also increases the risk of comorbidities such as heart disease, osteoporosis, and kidney disease. This Empowering Lupus Research Partnership cohort will accelerate discoveries that improve care and outcomes for people living with lupus.
“The Empowering Lupus Research Partnership drives progress in rheumatology and lupus research, supports investigators, and offers hope to those affected by rheumatic disease,” Marchiolo concluded.
2026 Lupus Research Alliance & Rheumatology Research Foundation Award Recipients Scientist Development Award Project: Machine learning based predictive models for systemic lupus erythematosus diagnosis and prevention Project: The immunometabolite Itaconate as a novel driver of TLR7-mediated Systemic Lupus Erythematosus (SLE) Project: Dissecting phenotypic heterogeneity in endosomal TLR-driven autoimmunity using human UNC93B1 allelic variants Project: Comprehensive multiomic analysis of the basis for cardiovascular risk in rheumatic disease Project: Understanding the Menopausal Transition in SLE: Symptom Burden and Therapeutic Implications The Lupus Research Alliance is the largest non-governmental, non-profit funder of lupus research worldwide.
The organization aims to transform treatment by funding the most innovative lupus research, fostering scientific talent, and driving discovery toward better diagnostics, improved treatments and, ultimately, a cure for lupus. Because the Lupus Research Alliance’s Board of Directors funds all administrative and fundraising costs, 100% of all donations go to support lupus research programs.
The Rheumatology Research Foundation is one of the largest private funding sources of rheumatology research and training programs in the U.S. Established in 1985, the Foundation is focused on advancing patient care and accelerating discoveries in rheumatic diseases. More information about the Foundation can be found at rheumresearch. org .
Tags: Rheumatology Research Foundation , Empowering Lupus Research , RRF , early research , early career
Based on current listing details, eligibility includes: Early-career scientists and junior investigators. Submissions undergo rigorous peer review led by the Foundation's Peer Review Study Sections. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $225,000 over three years Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.